Use este identificador para citar ou linkar para este item:
https://repositorio.inpa.gov.br/handle/1/17604
Registro completo de metadados
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Montoia, Andréia | - |
dc.contributor.author | Silva, Luiz Francisco Rocha e | - |
dc.contributor.author | Torres, Zelina Estevam dos Santos | - |
dc.contributor.author | Costa, David Siqueira | - |
dc.contributor.author | Henrique, Marycleuma Campos | - |
dc.contributor.author | Lima, Emerson Silva | - |
dc.contributor.author | Vasconcellos, Marne Carvalho de | - |
dc.contributor.author | Souza, Rita C.Z. | - |
dc.contributor.author | Costa, Mônica Regina Farias | - |
dc.contributor.author | Grafov, Andrèi Andriy | - |
dc.contributor.author | Grafova, Iryna A. | - |
dc.contributor.author | Eberlin, M. N. | - |
dc.contributor.author | Tadei, Wanderli Pedro | - |
dc.contributor.author | Amorim, Rodrigo C.N. | - |
dc.contributor.author | Pohlit, Adrian Martin | - |
dc.date.accessioned | 2020-06-15T21:48:29Z | - |
dc.date.available | 2020-06-15T21:48:29Z | - |
dc.date.issued | 2014 | - |
dc.identifier.uri | https://repositorio.inpa.gov.br/handle/1/17604 | - |
dc.description.abstract | Ellipticine has been shown previously to exhibit excellent in vitro antiplasmodial activity and in vivo antimalarial properties that are comparable to those of the control drug chloroquine in a mouse malaria model. Ellipticine derivatives and analogs exhibit antimalarial potential however only a few have been studied to date. Herein, ellipticine and a structural analog were isolated from Aspidosperma vargasii bark. A-ring brominated and nitrated ellipticine derivatives exhibit good in vitro inhibition of Plasmodium falciparum K1 and 3D7 strains. Several of the compounds were found not to be toxic to human fetal lung fibroblasts. 9-Nitroellipticine (IC50 = 0.55 μM) exhibits greater antiplasmodial activity than ellipticine. These results are further evidence of the antimalarial potential of ellipticine derivatives. © 2014 Elsevier Ltd. All rights reserved. | en |
dc.language.iso | en | pt_BR |
dc.relation.ispartof | Volume 24, Número 12, Pags. 2631-2634 | pt_BR |
dc.rights | Restrito | * |
dc.subject | 2 Methyl 1,2,3,4 Tetrahydroellipticine | en |
dc.subject | 3,4 Dihydroellipticine | en |
dc.subject | 7 Nitroellipticine | en |
dc.subject | 7,8,9 Tribromoellipticine | en |
dc.subject | 7,9 Dibromoellipticine | en |
dc.subject | 9 Bromoellipticine | en |
dc.subject | 9 Hydroxyellipticine | en |
dc.subject | 9 Methoxyellipticine | en |
dc.subject | 9 Nitroellipticine | en |
dc.subject | Antimalarial Agent | en |
dc.subject | Chloroquine | en |
dc.subject | Ellipticine | en |
dc.subject | Ellipticine Derivative | en |
dc.subject | Olivacine | en |
dc.subject | Unclassified Drug | en |
dc.subject | Antimalarial Agent | en |
dc.subject | Chloroquine | en |
dc.subject | Ellipticine | en |
dc.subject | Ellipticine Derivative | en |
dc.subject | 2 Methyl 1,2,3,4 Tetrahydroellipticine | en |
dc.subject | 7 Nitroellipticine | en |
dc.subject | 7,9 Dibromoellipticine | en |
dc.subject | 9 Nitroellipticine | en |
dc.subject | Antimalarial Agent | en |
dc.subject | Chloroquine | en |
dc.subject | Ellipticine | en |
dc.subject | Ellipticine Derivative | en |
dc.subject | Olivacine | en |
dc.subject | Quinine Sulfate | en |
dc.subject | Antimalarial Activity | en |
dc.subject | Aspidosperma | en |
dc.subject | Aspidosperma Vargasii | en |
dc.subject | Bark | en |
dc.subject | Bromination | en |
dc.subject | Controlled Study | en |
dc.subject | Drug Cytotoxicity | en |
dc.subject | Drug Effect | en |
dc.subject | Drug Isolation | en |
dc.subject | Drug Potency | en |
dc.subject | Fetus | en |
dc.subject | Human | en |
dc.subject | Human Cell | en |
dc.subject | Ic 50 | en |
dc.subject | In Vitro Study | en |
dc.subject | Lung Fibroblast | en |
dc.subject | Medicinal Plant | en |
dc.subject | Nitration | en |
dc.subject | Nonhuman | en |
dc.subject | Plasmodium Berghei | en |
dc.subject | Plasmodium Falciparum | en |
dc.subject | Animals | en |
dc.subject | Chemical Structure | en |
dc.subject | Chemistry | en |
dc.subject | Disease Model | en |
dc.subject | Drug Effects | en |
dc.subject | Fibroblast | en |
dc.subject | Mouse | en |
dc.subject | Synthesis | en |
dc.subject | Animals Cell | en |
dc.subject | Animals Experiment | en |
dc.subject | Animals Model | en |
dc.subject | Antiplasmodial Activity | en |
dc.subject | Aspidosperma | en |
dc.subject | Aspidosperma Vargasii | en |
dc.subject | Carbon Nuclear Magnetic Resonance | en |
dc.subject | Drug Structure | en |
dc.subject | Drug Synthesis | en |
dc.subject | Macrophage | en |
dc.subject | Malaria | en |
dc.subject | Malaria Control | en |
dc.subject | Mass Spectrometry | en |
dc.subject | Parasitemia | en |
dc.subject | Proton Nuclear Magnetic Resonance | en |
dc.subject | Aspidosperma | en |
dc.subject | Plasmodium Falciparum | en |
dc.subject | Animal | en |
dc.subject | Antimalarials | en |
dc.subject | Aspidosperma | en |
dc.subject | Chloroquine | en |
dc.subject | Disease Models, Animals | en |
dc.subject | Ellipticines | en |
dc.subject | Fibroblasts | en |
dc.subject | Humans | en |
dc.subject | Mice | en |
dc.subject | Molecular Structure | en |
dc.subject | Plant Bark | en |
dc.subject | Plasmodium Falciparum | en |
dc.title | Antiplasmodial activity of synthetic ellipticine derivatives and an isolated analog | en |
dc.type | Artigo | pt_BR |
dc.identifier.doi | 10.1016/j.bmcl.2014.04.070 | - |
dc.publisher.journal | Bioorganic and Medicinal Chemistry Letters | pt_BR |
Aparece nas coleções: | Artigos |
Arquivos associados a este item:
Não existem arquivos associados a este item.
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.